Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability

Monica Centa*, Hong Jin, Lisa Hofste, Sanna Hellberg, Albert Busch, Roland Baumgartner, Nienke J Verzaal, Sara Lind Enoksson, Ljubica Perisic Matic, Sanjay V Boddul, Dorothee Atzler, Daniel Y Li, Changyan Sun, Göran K Hansson, Daniel F J Ketelhuth, Ulf Hedin, Fredrik Wermeling, Esther Lutgens, Christoph J Binder, Lars MaegdesfesselStephen G Malin

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

BACKGROUND: Atherosclerosis progression is modulated by interactions with the adaptive immune system. Humoral immunity can help protect against atherosclerosis formation; however, the existence, origin, and function of putative atherogenic antibodies are controversial. How such atherosclerosis-promoting antibodies could affect the specific composition and stability of plaques, as well as the vasculature generally, remains unknown.

METHODS: We addressed the overall contribution of antibodies to atherosclerosis plaque formation, composition, and stability in vivo (1) with mice that displayed a general loss of antibodies, (2) with mice that had selectively ablated germinal center-derived IgG production, or (3) through interruption of T-B-cell interactions and further studied the effects of antibody deficiency on the aorta by transcriptomics.

RESULTS: Here, we demonstrate that atherosclerosis-prone mice with attenuated plasma cell function manifest reduced plaque burden, indicating that antibodies promote atherosclerotic lesion size. However, the composition of the plaque was altered in antibody-deficient mice, with an increase in lipid content and decreases in smooth muscle cells and macrophages, resulting in an experimentally validated vulnerable plaque phenotype. Furthermore, IgG antibodies enhanced smooth muscle cell proliferation in vitro in an Fc receptor-dependent manner, and antibody-deficient mice had decreased neointimal hyperplasia formation in vivo. These IgG antibodies were shown to be derived from germinal centers, and mice genetically deficient for germinal center formation had strongly reduced atherosclerosis plaque formation. mRNA sequencing of aortas revealed that antibodies are required for the sufficient expression of multiple signal-induced and growth-promoting transcription factors and that aortas undergo large-scale metabolic reprograming in their absence. Using an elastase model, we demonstrated that absence of IgG results in an increased severity of aneurysm formation.

CONCLUSIONS: We propose that germinal center-derived IgG antibodies promote the size and stability of atherosclerosis plaques, through promoting arterial smooth muscle cell proliferation and maintaining the molecular identity of the aorta. These results could have implications for therapies that target B cells or B-T-cell interactions because the loss of humoral immunity leads to a smaller but less stable plaque phenotype.

Original languageEnglish
JournalCirculation
Volume139
Issue number21
Pages (from-to)2466-2482
ISSN0009-7322
DOIs
Publication statusPublished - 21. May 2019
Externally publishedYes

Fingerprint Dive into the research topics of 'Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability'. Together they form a unique fingerprint.

  • Cite this

    Centa, M., Jin, H., Hofste, L., Hellberg, S., Busch, A., Baumgartner, R., Verzaal, N. J., Lind Enoksson, S., Perisic Matic, L., Boddul, S. V., Atzler, D., Li, D. Y., Sun, C., Hansson, G. K., Ketelhuth, D. F. J., Hedin, U., Wermeling, F., Lutgens, E., Binder, C. J., ... Malin, S. G. (2019). Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability. Circulation, 139(21), 2466-2482. https://doi.org/10.1161/CIRCULATIONAHA.118.038534